The FDA says that potassium iodide (KI) works only to prevent radioactive iodine from being taken up by the thyroid gland, and that it "is not a general radioprotective agent." The Nuclear Regulatory Commission (NRC) says that, if taken properly, KI may reduce how much radioactive iodine the thyroid gland is able to absorb. This page sets out what the two agencies say and adds no advice of its own.
What KI does and does not do
The FDA says KI "floods the thyroid with non-radioactive iodine and prevents the uptake of the radioactive molecules, which are subsequently excreted in the urine." The table sets out what the FDA's answers say KI does and does not do.
| What the FDA says KI does | What the FDA says KI does not do |
|---|---|
| Reduces the uptake of radioactive iodine into the thyroid gland | Protect against radiation from bombs other than radioactive iodine, such as a dirty bomb |
| Reduces the risk of thyroid cancer when given in the recommended dose to people at risk from inhaling or ingesting radioiodines | Serve as a preventative taken before radiation exposure, which the FDA says it should not be |
| Is available without a prescription | Replace the instructions of local officials, who say whether to take it after an event in the United States |
Who the FDA says needs it most
The FDA says its guidance prioritizes groups by age, because age is the primary factor for risk of radioiodine-induced thyroid cancer. It says infants and children, and pregnant and nursing females, are at highest risk, because KI can suppress thyroid function in a developing fetus and a newborn, and that they should be treated at the lowest threshold. It says anyone over 18 and up to 40 should be treated at a slightly higher threshold, and that anyone over 40 should be treated with KI only if the predicted exposure is high enough to destroy the thyroid and induce lifelong hypothyroidism.
Dosing by age group
The FDA lists a threshold for each risk group, the predicted thyroid gland exposure in centigrays (cGy) at which it recommends KI, with the dose for that group. Its full table has more columns than fit on this page, so the numbers are shown in two tables, both copied from the FDA.